The Induction of IL-6 by NF-kB in PBMC in OSA

计划入组 20 人 · 首次发布于 2007 年 7 月 10 日

Effects of Physical Activities on the Expression of Nrf2 and Nf-kb Hemodialysis Patients

计划入组 40 人 · 首次发布于 2016 年 3 月 24 日

Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients

首次发布于 2011 年 1 月 4 日

NF-kappaB Decoy

NF-kB inhibitor (Henan University)

NF-kB inhibitors (spinal cord injury)

Pathway Therapeutics, Inc.

United States

KB Financial Group Inc.

South Korea

Depo NF Sub, LLC

United States

NFKB1 Haplotype Predicts Improved Response to Ropeginterferon Alfa-2b in PV and ET

Recursion Doses First Patient in Phase 1 Trial of REC-3565 for Relapsed B-cell Lymphomas

Curis Opens Eleven Clinical Sites for Phase 2 TakeAim CLL Study of Emavusertib–Zanubrutinib Combination